Smilow Shares: HBOC Cancer Risks, Part 2
Smilow Shares features talks on genetic counseling and testing. On October 6th, an overview of risk factors for pancreatic cancers and screening for men w/ HBC Syndromes, melanoma, prostate, and others was discussed along with a talk on Breast Reconstruction Options.
A COVID-19 Update for our Patients and Families
Smilow Cancer Hospital and our Smilow Cancer Hospital Care Centers are closely monitoring the spread of COVID-19 (Coronavirus) and are taking extra precautions to protect our patients and their families. Patients with cancer often have a weakened immune system, or are immunosuppressed, and are at an increased risk of infection, the flu, and other viruses.
Information for our Patients about COVID–19 from Smilow Cancer Hospital
Smilow Cancer Hospital is closely monitoring the spread of novel coronavirus (COVID-19) and is taking extra precautions to protect our patients and their families. Patients with cancer often have a weakened immune system, or are immunosuppressed, and are at an increased risk of infection, the flu, and other viruses.
Donors Making a Difference: Physician, Researcher and Author C. Richard Boland, MD, (YSM ’73) Accelerates Research Surrounding Familial and Hereditary Gastrointestinal Cancers with Recent Gift
Inspired by an intense curiosity about his family’s long history with colon and other cancers and a desire to help his and other families with similar cancer histories, C. Richard Boland, MD, ’73 has devoted his entire medical career to finding the causes of hereditary colorectal cancer.
Most Breast Cancer Patients Fail to Get Genetic Counseling
Fewer than half of newly diagnosed breast cancer patients who should have received formal genetic counseling actually got it, survey data indicated. Among 1,711 early-stage breast cancer patients with indications for counseling, 43.5% received formal genetic risk counseling, while 31.1% had a discussion with their physician about their genetic risk and 25.4% had no discussion whatsoever.Source: MedPage Today
Yale Cancer Center research highlighted at 2017 SABCS
Yale Cancer Center (YCC) researchers attended the 40th annual San Antonio Breast Cancer Symposium (SABCS), from December 5-9, and bringing news of major advances against a disease that strikes more than 250,000 women and men in the United States each year. The Symposium is a five-day program attended by an international audience of academic and private researchers and physicians from over 90 countries.
The Pill Has Prevented 200,000 Endometrial Cancer Cases in the Last Decade Alone
Experts have known that women who take birth-control pills have a lower risk of endometrial cancer, and a new study offers insight into how long the protective effect lasts and how many cancer cases have likely been prevented.Source: New York Magazine
Yale Cancer Center Launches Weekly Radio Program on WTIC-AM
Yale Cancer Center (YCC) is broadcasting “Healthline,” a weekly radio program that airs from 8:30-9:00 a.m. every Sunday on WTIC NewsTalk 1080 AM. Healthline is co-hosted by Kenneth Miller, M.D., director of the survivorship program and Edward Chu, M.D., Chief of Medical Oncology at YCC. Each week they will be joined by a different cancer specialist, bringing the innovation and expertise of YCC to all of Connecticut.